Page last updated: 2024-08-23

substance p and Respiratory Syncytial Virus Infections

substance p has been researched along with Respiratory Syncytial Virus Infections in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (91.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bermudez, J; Espina, LM; Giuffrida, M; Gotera, J; Maldonado, M; Mavarez, A; Mosquera, J; Pons, H; Valero, N1
Anderson, LJ; Barskey, A; Goss, L; Tripp, RA1
Adkins, B; Auais, A; Napchan, G; Piedimonte, G1
Piedimonte, G2
Graham, BS; Johnson, TR1
Balhorn, A; Dakhama, A; El Gazzar, M; Gelfand, EW; Joetham, A; Kanehiro, A; Kodama, T; Larsen, GL; Loader, JE; Miyahara, N; Park, JW; Takeda, K; Taube, C1
Goldbart, AD; Goldman, JL; Gozal, D; Kheirandish-Gozal, L; Mager, E; Piedimonte, G; Serpero, LD; Veling, MC1
Booth, JA; Correia, JB; Dankert, HM; Ebrahimi, B; Hart, CA; Semple, MG; Smyth, RL; Stewart, JP1
Anderson, LJ; Moore, D; Tripp, RA; Winter, J1
Hu, C; Jiang, X; King, KA; Piedimonte, G; Rodriguez, MM; Romaguera, R1
Anderson, LJ; Haynes, LM; Tonkin, J; Tripp, RA1

Reviews

3 review(s) available for substance p and Respiratory Syncytial Virus Infections

ArticleYear
Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:2 Suppl

    Topics: Animals; Asthma; Capillary Permeability; Child; Child, Preschool; Disease Models, Animal; Humans; Infant; Infant, Newborn; Lung; Muscle, Smooth; Nerve Growth Factors; Neuronal Plasticity; Pneumonia; Rats; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Risk Factors; Substance P; T-Lymphocytes

2003
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:1 Suppl

    Topics: Animals; Antigens, Viral; Disease Models, Animal; Epitopes; Female; Glycoproteins; Immunity; Immunization; Interleukin-4; Interleukin-8; Male; Mice; Mice, Inbred BALB C; Pulmonary Eosinophilia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sensitivity and Specificity; Severity of Illness Index; Substance P; Viral Vaccines

2004
Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae.
    American journal of respiratory and critical care medicine, 2001, Volume: 163, Issue:3 Pt 2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchiolitis, Viral; Humans; Models, Immunological; Neural Pathways; Neuroimmunomodulation; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory System; Substance P

2001

Other Studies

9 other study(ies) available for substance p and Respiratory Syncytial Virus Infections

ArticleYear
Respiratory syncytial virus infection increases regulated on activation normal T cell expressed and secreted and monocyte chemotactic protein 1 levels in serum of patients with asthma and in human monocyte cultures.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2012, Volume: 108, Issue:5

    Topics: Adult; Aged; Asthma; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphocyte Activation; Male; Middle Aged; Monocytes; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Substance P; T-Lymphocytes; Up-Regulation

2012
Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection.
    Journal of neuroimmunology, 2002, Volume: 129, Issue:1-2

    Topics: Animals; Antibody Specificity; Antigens, CD; Antigens, Surface; CD8-Positive T-Lymphocytes; Chemotaxis, Leukocyte; Cytokines; Female; Gene Expression Regulation; Leukosialin; Ligands; Lung; Mice; Mice, Inbred BALB C; Parainfluenza Virus 3, Human; Protein Binding; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respirovirus Infections; Sialoglycoproteins; Substance P; T-Lymphocytes; Th1 Cells; Th2 Cells

2002
Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats.
    American journal of physiology. Lung cellular and molecular physiology, 2003, Volume: 285, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Asthma; Leukocyte Count; Lung; Lymphocyte Subsets; Male; Monocytes; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Piperidines; Pneumonia, Viral; Rats; Rats, Inbred F344; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Specific Pathogen-Free Organisms; Substance P

2003
Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection.
    American journal of physiology. Lung cellular and molecular physiology, 2005, Volume: 288, Issue:4

    Topics: Animals; Antiemetics; Calcitonin Gene-Related Peptide; Humans; Inflammation; Lung; Mice; Mice, Inbred BALB C; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Pyrrolidonecarboxylic Acid; Respiratory Hypersensitivity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Substance P

2005
Neurotrophins and tonsillar hypertrophy in children with obstructive sleep apnea.
    Pediatric research, 2007, Volume: 62, Issue:4

    Topics: Adenoids; Brain-Derived Neurotrophic Factor; Child; Child, Preschool; Female; Humans; Hypertrophy; Male; Nerve Growth Factor; Nerve Growth Factors; Palatine Tonsil; Receptor, trkA; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; RNA, Messenger; Sleep Apnea, Obstructive; Substance P; Tonsillitis

2007
Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.
    PloS one, 2007, Oct-17, Volume: 2, Issue:10

    Topics: Bronchiolitis; Female; Humans; Immunity, Innate; Infant; Infant, Newborn; Interferon-gamma; Interleukin-9; Male; Oxygen; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory System; Substance P; Urea

2007
Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
    Journal of virology, 2000, Volume: 74, Issue:4

    Topics: Animals; Antigens, Viral; Bronchiolitis; Bronchoalveolar Lavage; CD3 Complex; Chlorocebus aethiops; Cytokines; Female; HN Protein; Humans; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Substance P; T-Lymphocytes; Vero Cells; Viral Envelope Proteins; Viral Proteins

2000
Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats.
    American journal of respiratory cell and molecular biology, 2001, Volume: 24, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Body Weight; Cell Line; DNA Primers; Humans; Immunoenzyme Techniques; Lung; Neurogenic Inflammation; Neuropeptides; Piperidines; Rats; Rats, Inbred F344; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Vasoactive Intestinal Peptide; Respiratory Syncytial Virus Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P; Up-Regulation

2001
Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.
    Journal of virology, 2002, Volume: 76, Issue:14

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Viral; Cytokines; Female; Inflammation; Lung; Mice; Mice, Inbred BALB C; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Substance P; Treatment Outcome; Viral Proteins; Virus Replication

2002